PATENT CLAIM ANALYSIS

Application Number: 16363378
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "464000"]

Abstract:
Provided herein are capsules containing pimavanserin, processes for manufacturing said capsule, and pharmaceutical compositions containing pimavanserin.

Claim (Index 1):
A pharmaceutically acceptable capsule for orally delivering 34 mg of pimavanserin to a patient, wherein the capsule has a capsule shell that encapsulates a blended pimavanserin composition comprising:\n 40 mg granulated pimavanserin tartrate having a particle size distribution (D90) of 180 to 340 \u03bcm, wherein the bulk density of the granulated pimavanserin is 0.4 to 0.6 g/ml as determined by USP<616>, method 1; 59 mg microcrystalline cellulose having a particle size distribution (D90) of 180 to 340 \u03bcm; and 1 mg magnesium stearate; wherein the particle size distribution is measured using laser light scattering with a Malvern Mastersizer 2000 LLS PS system, a Scirocco 2000 dry dispersion unit and a sample size of 2 to 10 g.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14661693', '13643386', '14430273', '14087903', '11606222']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.742234085150737
- 35 USC 102 Novelty (BERT): 0.5005929695635082
- Combined Prediction Score: 0.7180699735920141
- Mean Citation Score: 159.97018799999995
- Max Citation Score: 161.94162
- Similarity Product: 105.35759896660925

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test